EyeWorld China December 2017

ĘNJˈlj Ѯ ŭ ʃ 40 EWAP ঃᓜᄌ ʼn ٵ ˖Ʀ㥠̡뺯Ԩʌ뻟׷Ŷ ŊĈĘѱ݀˫뻟ʼnᅻȒć׷Ŷ ĐĜŜƍ뺯ȂˤƋ׷ֶŀằđ ć ̡ ޣڽ ğԇĉ뺯 ĐŶďă ̀đˈਝ࠴Šٜͽ ۽ ˀ뺯āĶģ ĻŘʼn ٵ ˖Ş ܭ ਐˊɕƦăĄ˱ ɕ뻟r&T 5VWNVKPI ĸ뺯 &T 5VWNVKPI ĸ뻟ĕƞ ڐ ׷ ĀԨĂċČ̎ĄയҽĴǎ뺯qभ ֆٌĀȀɛĴǎȂĉƦ ࡋ 뺯भֆ ٌĀȀɛĴǎĈĂȏ٩ԏȂٌ뻟 āĶȢćɘDŽ ތࠕ Ѥ҄şȪ뺯ʙ ˩āĶģĩѿƙė œѨУ ėԴ੾ࣳŠ뻟ƦăĄǁ۬ ڐ ׷ Ā œѨ뺯Ȯਮ͠ĀȹԙԴʇ ğ뻟āĶĻŘźਮ͠Ď뻟Դ੾Ȁ ɛ œѨ뻟 ܋ݕ ǘயʌϞĪ œѨ뻟 Ůɕls޿ œѨ뻟 Đ ă ٵ ˖뻟 ĐฎҫČĀ˸ƺ뺯च ůǁ۬ ڐ ׷뻟 ܭ ਐĂɕψɺ Ň Ĵ뻟āĶĂơŮĩ ܭ ਐĂŮɕ뻟r Ŵĸ뺯 '9#2 ϩҨNJଣ 1. O’Brart DPS. Corneal collagen crosslinking for corneal ectasias: a review. Eur J Ophthalmol. 2017;27:253–269. 2. Shalchi Z, et al. Safety and efficacy of epithelium removal and transepithelial corneal collagen crosslinking for keratoconus Eye (Lond). 2015;29:15–29. 3. Elling M, et al. Photorefractive intrastromal corneal crosslinking for the treatment of myopic refractive errors: Six-month interim findings. J Cataract Refract Surg. 2017;43:789– 795. ৠ٧ͩ뻭 Dr. Stulting Š CXL Ophthalmics (Encinitas 뻟 California) Ĉ ǁ࢖ϙॼȱͷ뺯 Dr. Elling ŠŴĀӇ ΡŊĈǁ࢖ϙॼȱͷ뺯 ԓͷƶК Elling: Matthias.elling@kk-bochum.de Stulting: dstulting@woolfsoneye.com